News for Progyny, Inc. (PGNY)

Insights from the First Quarter 2025 13F Filing Robert Olstein (Trades, Portfolio) recently submitted the 13F filing for the first quarter of 2025, providing i

U.S. stock futures were higher this morning, with the Dow futures gaining around 300 points on Monday. Shares of James Hardie Industries plc JHX fell sharply i...

**media[563435]**

Progyny Inc (PGNY), a leading provider of fertility, family building, and women's health benefits solutions, announced on March 7, 2025, its participation in se

**media[560497]**

Progyny Inc (PGNY) demonstrates a robust market presence with a unique Smart Cycle approach and a high Net Promoter Score.The company faces intense competition

Revenue (Q4 2024): $298.4 million, up 11% year-over-year.Full Year Revenue (2024): $1.17 billion, up 7% year-over-year.Medical Revenue (Q4 2024): $188 million,

Feb 27, 2025 / 09:45PM GMTOperator Good day, ladies and gentlemen, and welcome to the Progeny Inc. fourth-quarter earnings conference call. (Operator Instructio

Progyny, Inc. (NASDAQ:PGNY) Q4 2024 Earnings Conference Call February 27, 2025 4:45 PM ETCompany ParticipantsJames Hart - Investor RelationsPete Anevski -...

Progyny Inc (PGNY), a leading provider of fertility and family building benefits, announced its financial results for the fourth quarter and full year of 2024,

Reports Quarterly Revenue of $298.4 Million, Reflecting 10.6% GrowthGenerated $52.2 Million of Quarterly Operating Cash FlowIssues Financial Guidance for 2025,

Revenue: $298.4 million for Q4 2024, surpassing the estimated $276.68 million and reflecting a 10.6% year-over-year growth.Earnings Per Share (EPS): Achieved $

**media[552833]**

Progyny Inc (PGNY) is set to release its Q4 2024 earnings on February 27, 2025. The consensus estimate for Q4 2024 revenue is $276.68 million, and the earnings

Progyny (PGNY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

**media[540301]**

Analysis on Progyny, Inc. stock: Insights on recent performance, challenges, and potential opportunities for investors. Click for more on PGNY stock prospects.

Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Progyny (PGNY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.